论文部分内容阅读
目的探讨精胰岛素联合瑞格列奈治疗2型糖尿病临床疗效.方法选取我院2012年9月~2013年9月收治的2型糖尿病患者42例为研究对象,对所有患者给予甘精胰岛素联合瑞格列奈进行治疗,比较治疗前后血糖事件发生率、2 h PBG(餐后2 h血糖)、FPG(空腹血浆葡萄糖)、BMI(体重指数)及红蛋白变化.结果患者的2 h PBG、FPG、BMI较治疗前明显下降,低血糖风险事件发生率明显降低,仅为4.76%,且无严重低血糖情况发生.结论甘精胰岛素联合瑞格列奈治疗2型糖尿病具有很好的临床疗效,能有效降低2 h PBG、FPG、BMI值和有效控制低血糖的发生率,值得在临床上推广. “,”Objective To study the insulin associated ziggy nai,clinical efficacy in the treatment of type 2 diabetes. Methods Our hospital between September 2012 and September 2013,42 patients with type 2 diabetes mellitus in our hospital as the research object,to all of the patients to give insulin joint nai raigor column treatment,compared before and after treatment the blood sugar eents,2 HPG,FPG,BMI and red protein changes. Results The patients with 2 HPG,FPG,BMI was significantly decreased,the significantly lower incidence of hypoglycemia risk events,only 4.76%,and no severe hypoglycemia occurs. Conclusion Insulin Craig column nai joint has good clinical efficacy in the treatment of type 2 diabetes,can effectively reduce 2 HPG,FPG,BMI,and effectively control the incidence of hypoglycemia,is worth popularizing in clinic.